Regulatory mechanism and functional analysis of S100A9 in acute promyelocytic leukemia cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulatory mechanism and functional analysis of S100A9 in acute promyelocytic leukemia cells
Authors
Keywords
<em class=EmphasisTypeItalic >S100A9</em>, PU.1, PML/RARα, ATRA, APL
Journal
Frontiers of Medicine
Volume 11, Issue 1, Pages 87-96
Publisher
Springer Nature
Online
2017-01-07
DOI
10.1007/s11684-016-0469-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PU.1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation
- (2016) Shuyong Wei et al. Journal of Hematology & Oncology
- Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer’s Disease
- (2015) Istvan Horvath et al. ACS Chemical Neuroscience
- Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
- (2015) David Chau et al. Journal of Hematology & Oncology
- S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy
- (2014) W. T. Kim et al. ANNALS OF ONCOLOGY
- Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype
- (2014) L van Bon et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanism of interleukin-1α transcriptional regulation of S100A9 in a human epidermal keratinocyte cell line
- (2013) Mika Bando et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia
- (2013) Maoxiang Qian et al. Journal of Hematology & Oncology
- S100A8/A9 (Calprotectin) Negatively Regulates G2/M Cell Cycle Progression and Growth of Squamous Cell Carcinoma
- (2013) Ali Khammanivong et al. PLoS One
- The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment
- (2012) Jae Hak Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia
- (2012) Yingmei Zhang et al. CANCER
- S100A8 and S100A9: New Insights into Their Roles in Malignancy
- (2011) Geetha Srikrishna Journal of Innate Immunity
- S100A8/A9: A Potential New Diagnostic Aid for Acute Appendicitis
- (2010) John F. Bealer et al. ACADEMIC EMERGENCY MEDICINE
- PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
- (2010) Kankan Wang et al. CANCER CELL
- A novel p53 target gene,S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway
- (2009) Chunsun Li et al. BIOCHEMICAL JOURNAL
- Consistent Deregulation of Gene Expression between Human and Murine MLL Rearrangement Leukemias
- (2009) Z. Li et al. CANCER RESEARCH
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
- (2008) M. H. Tomasson et al. BLOOD
- A review of the S100 proteins in cancer
- (2007) I. Salama et al. EJSO
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation